Johnson & Johnson

Janssen's Cancer Care at ASCO and EHA

Janssen’s Transformational Cancer Care at ASCO and EHA

Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting will feature […]

Janssen’s Transformational Cancer Care at ASCO and EHA Read More »

Janssen Collaborates with CBMG to Develop CAR-T Therapies

Janssen Collaborates with CBMG to Develop CAR-T Therapies

Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies  Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has announced that it has entered into a worldwide collaboration and license agreement with Cellular Biomedicine Group Inc. (CBMG) to develop, manufacture and commercialize next-generation

Janssen Collaborates with CBMG to Develop CAR-T Therapies Read More »